1 / 24

Heart - cardiomyocyte - vascular endothelial cell - smooth muscle cell

Heart - cardiomyocyte - vascular endothelial cell - smooth muscle cell A heart attack = myocardial infarction - occurs in nearly 1.1 million Americans each year. - be the result of hypertension, chronic insufficiency in the blood supply to the heart

ferdinand-cameron
Download Presentation

Heart - cardiomyocyte - vascular endothelial cell - smooth muscle cell

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Heart - cardiomyocyte - vascular endothelial cell - smooth muscle cell A heart attack = myocardial infarction - occurs in nearly 1.1 million Americans each year. - be the result of hypertension, chronic insufficiency in the blood supply to the heart muscle caused by coronary artery disease, or a heart attack - treatment: surgical procedures, mechanical assistance devices, drug therapy, and organ transplantation - Researchers are now exploring ways to save additional lives by using replacement cells for dead or impaired cells - There is still no evidence that there are true stem cells in the heart which can proliferate and differentiate. What is the evidence that a stem cell therapy approach to restoring cardiac function might work? - a mouse or rat model of a heart attack to study new therapies

  2. Why Cell Therapy for Damaged Heart ? “Adult” Cardiomyocytes # No potential for regeneration after birth # No capacity to reenter cell cycle in adult mammalian heart Rumyantsev PP, Int Rev Cytol, 1977 # Cardiomyocytes respond to mitotic signals by cell hypertrophy rather than by cell hyperplasia Kodama H, et al., Circ Res, 1997 Pan J, et al., Circ Res, 1997 “Therefore” Loss of cardiomyocyte will result in permanent reduction of number of functioning units in myocardium Classification of Etiology of Heart Failure Contractile Dysfunction Ischemic heart disease Cardiomyopathies (dilated) Pressure Overload Aortic stenosis Hypertension Pulmonary hypertension Volume Overload Aortic regurgitation Mitral regurgitation Ventricular septal defect Inadequate Filling Amyloidosis Constrictive pericarditis Arrhythmia

  3. Dilated Cardiomyopathy Myocardial Infarction Myocytes Changes in Heart Failure Reduced ATP Supply Reduced responsiveness to catecholamines Coronary Atherothrombosis & Myocardial Infarction Reduced Myofilament Volume Contractile Dysfunction “Exhausted phase” Myocyte dropout  “Decreased Contractility”

  4. Drug Therapy Surgical Procedures Mechanical Assistant Device Organ Transplantation Death

  5. Then, what do we consider for Heart Cell Transplantation ? Cell Therapy might be an Alternative for a Damaged Heart !!! Cell Source ? Sufficient Amount ? Survive ? Integrate ? Improve Heart Function ? Advantages over organ transplantation 1. Transplantation of one cell type 2. Earlier angiogenesis 3. Less traumatic 4. Implantation at a specific site Transplantation with Non-CMC is O.K. !!!….? Skeletal myoblast (Satellite cell) Koh GY, et al., J Clin Invest, 1993 Taylor DA, et al., Nature Med, 1998 Yoon PD, et al., Tex Heart Inst J, 1995 Chiu RCJ, et al., Ann Thorac Surg, 1995 Fetal enteric smooth muscle cell Li R-K, et al., J Moll Cell Cardiol, 1999 Kumar A, et al., Natl Acad Sci U S A, 1997 Fetal skin fibroblast Sakai T, et al., J Thorac Cardiolvasc Surg, 1999

  6. Skeletal Myoblast (C2C12) Graft in Heart “Satellite cell” Comparison of LV Remodeling after 3-Type-Cell Transplantation Koh GY, et al., J Clin Invest, 1993 CMC SMC Fibroblast LV volume index* 1.00  0.04 0.91  0.32 0.84  0.20 Scar thickness index 1.13  0.25 2.10  0.681 2.40  0.861 Scar area index 0.78  0.08 1.27  0.282 1.37  0.343 Transplantation area/scar area** 37.0  8.9 32.2  4.8 51.3  14.64 Sakai T, et al., J Thorac Cardiolvasc Surg, 1999

  7. Cardiac -Actin # Role of Actin Contractility Maintenance of cytoskeleton Cell division / Cell motility # At least 6 isoforms in higher vertebrates (4 muscular/2 non-muscular) # Remarkable conservation of muscle actins along with their tissue & developmental specificity Cardiac -actin-deficient mice Kumar A, et al., Proc Natl Acad Sci USA, 1997 Low survival to term / Death within 2 weeks after birth Homozygous mutants with increased expression of vascular smooth muscle & skeletal -actin : Insufficient to maintain myofibrillar integrity Rescue with enteric smooth muscle -actin : Extremely hypodynamic /Considerably enlarged / Hypertrophied “Therefore” Alteration in actin composition in heart are associated with severe structural & functional perturbations. O.K. , Cardiomyocytes may be the Best Donor Cells ! Fetal / Neonatal / Adult ? Xenogenic / Allogenic / Autologous ?

  8. Relaxed FS = 75% FS = 35% Graft of Fetal Cardiomyocytes from Transgenic Mice Evaluation of Contractility TEM analysis of fetal CMC grafts Soonpaa MH, et al., Science, 1994 developed Intercalated Discs between host & engrafted fetal CMC Contraction as early as 7 days after transplantation Long-axis length on day 21 after transplantation 0.60 ± 0.01 cm in relaxed state 0.21 ± 0.02 cm in contracting state Fractional Shortening = 35%

  9. Electromechanical Coupling of Neonatal & Adult CMC In Vitro Reinecke H, et al., Circulation, 1999 Green Red Cocultured neonatal & adult CMC Green Red Green Red Rhodamine filter Lucifer yellow filter Fate of Transplanted Fetal CMC Li R-K, et al., Circulation, 1997 After transplantation Transplant tissue (mm2) Scar tissue (mm2) 8 wk 20.7 ± 6.9 90.4 ± 25 24 wk 6 ± 6 162 ± 46 Lymphocyte infiltration surrounded cardiac tissue formed by transplanted CMC despite use of cyclosporin A “Allograft Rejection”

  10. Autologous Cardiomyocyte Transplantation In Adult Swine Model of Myocardial Infarction Li R-K, et al., Thorac Cardiovasc Surg, 2000 # 16 adult female Yorkshire swine (controls=8) # Generation of MI by Intraluminal coil occlusion of d-LAD # Sampling & culture of CMC by interventricular septal biopsies # Cell labeling with BrdU to identify transplanted cells # Cell transplantation after 4-week culture Cell suspension : 2 ml (107 cells/ml) Injection with tuberculin syringe Center / Periphery of infarct zone : No evidence of rejection at 4 weeks after transplantation Stem Cells are Versatile: Can Stem Cell Repair a Damaged Heart ? Generation of CMC from Embryonic Stem Cells Embryonic stem (ES) cells Totipotent cell line derived from inner cell mass of blastocysts Cardiogenic induction during ES differentiation Appearance of spontaneously and rhythmically contracting myocytes Expression of - & -MHC,  -tropomyosin, MLC-2v, ANF, & ….. Normal contractile sensitivity to calcium Action potentials typical for atrial, ventricular, & conduction system CMC Cell cycle withdrawal & multinucleation Prerequisite for donor cells Likely resulting in teratoma formation  Require generation of essentially pure CMC cultures

  11. Genetically Selected CMC from Differentiating ES Cells Klug MG, et al., J Clin Invest, 1996 # Genetically modified murine ES cell lines Transfection with “Fusion gene”(MHC-neor) -cardiac MHC promoter cDNA encoding aminoglycoside phophotransferase Expression of fusion gene in ES-derived CMC Selected with G418 after in vitro differentiation # Recipient : Heart of adult dystrophic mice (mdx mice) Relative CMC Content in Non-selected, Physically Selected, & G418 Selected Cultures of Differentiating ES cells Sarcomeric myosin Sarcomeric myosin Percent Preparation positive cells negative cells CMC No selection 11 2,000 0.55 Physical isolation 68 2,000 3.4 G418 selection 791 3 99.6

  12. G418 Selection of ES-derived CMC In Vitro & Formation of Intracardiac Grafts Dystrophin Non-selected culture G418-selected culture Recipient Titin -actin Donor Sarcomeric myosin Desmin Klug MG, et al., J Clin Invest, 1996

  13. Generation of CMC from Bone Marrow Stromal Cells Marrow stromal cells Pluripotential differentiating into bone, muscle, fat, tendon, or cartilage Differentiate into CMC ? 5-Azacytidine Cytosine analogue Alteration of expression of certain genes that may regulate differentiation Cardiomyocytes can be generated from marrow stromal cells in vitro Makino S, et al., J Clin Invest 1999; 103: 697-705 Autologous transplantation of bone marrow cells improve damaged heart function Tomita S, et al., Circulation 1999; 100[suppl II]: II-247-II-256 Cardiomyogenic Cell (CMG) Before & After 5-Azacytidine Treatment Phase-contrast photograph Makino S, et al., J Clin Invest, 1999

  14. Action Potential of CMG Myotubes a Sinus node-like AP b Ventricular CMC-like AP BM cells in culture before 5-Azacytidine Spindle-like mesenchymal stem cells BM cells cultured with 5-Azacytidine Forming network of myotubules Troponin I staining Makino S, et al., J Clin Invest, 1999 Tomita S, et al., Circulation, 1999

  15. Capillary with some RBC Troponin I BrdU-labeled BM transplant in LV free wall scar Tomita S, et al., Circulation, 1999 Transplanted BM cells stimulated angiogenesis !! Tomita S, et al., Circulation, 1999

  16. Scar area LV Function Analysis Scar thickness 5-aza BMC Morphological Analysis LV size 5-aza BMC Tomita S, et al., Circulation, 1999

  17. Derivation & potential applications of BM stroma-derived CMG cell lines Inject into myocardium for cell replacement therapy in patients with cardiomyopathy Genetically modify for cardiomyoctic cell replacement therapies Bone Marrow Hematopoietic Cells Passage 4 months in culture 5-Azacytidine Bone Marrow Stromal Cells Immortalized Bone Marrow Stromal Cells (CMG cells) Beating Cardiomyocytes Transfect with cDNA expression libraries to identify cardiomyocyte determining genes Leiden JM, J Clin Invest, 1999

  18. Locally Delivered BM Cells Can Regenerate do novo Myocardium Orlic D, et al., Nature, 2001 Injection of male Lin-c-kit+ BM cells in peri-infarcted LV of female mice Lin-c-kit+ Border Zone Regenerating Myocardium

  19. Unknown molecular “Signal(s)” BM cell migration to damaged area Proliferation & differentiation Cytoplasmic protein Cardiac myosin -Sarcomeric actin Connexin 43 Nuclear protein Csx/Nkx2.5 MEF2 GATA-4 Functional competence Proposed Scheme for Lin-c-kit+ Cell Differentiation in Cardiac Muscle Orlic D, et al., Nature, 2001 Transplanted BM cells Infarcted myocardium

  20. IV injection of G-CSF-mobilized CD34+ hBMC in rat tail AMI model Saline CD34+ hBMC Saline CD34+ hBMC Factor VIII Human CD34+ Human CD31 Rat CD31 Neovascularization of Ischemic Myocardium by Systemic Injection of hBM-derived Angioblasts Kocher AA, et al,. Nature Med 2001 Angiogenesis Vasculogenesis

  21. M Lethal irradiation SP cells (CD34-c-kit+Sca-1+) marked with LacZ gene (-) control for LacZ (+) control for LacZ F 10 weeks after transplantation for 60 min LacZ -actin Flt-1 2 or 4 weeks after injury (+) control for CD45 ICAM-1 -actin CD45 (-) Regeneration of Ischemic Cardiac Muscle & Vascular Endothelium by Transplanted Bone Marrow Stem Cells Jackson KA, et al., J Clin Invest, 2001

  22. Conclusions Adult & embryonic stem cells may be able to replace damaged heart muscle and establish new blood vessels to supply them. Functional role of adult (hematopoietic) stem cell may be ultimately determined by their migration into heart, and their exposure to locally generated signals at injured sites.

More Related